Deals Shaping The Medical Industry, May 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced March through April 2014

Roche paid $275mm up front for private molecular diagnostics company IQuum Inc., which is also eligible for $175mm in earn-outs based on product milestones. IQuum will become part of Roche Diagnostics Corp.’s Roche Molecular Diagnostics. (Apr.)

IQuum, established in 1998, focuses on rapid, point-of-care cellular, protein, and nucleic acid testing of biological samples. Its diagnostics, which...

More from Deal-Making

More from In Vivo